Walmart’s U.S. comparable sales ex-fuel have tracked 4.1% in Q1 FY2027 and 4.6% in the prior-year Q2, supported by grocery and health-and-wellness strength plus roughly 400 basis points of e-commerce contribution. Traders price the 3–4.5% bucket highest at 60.5% because recent quarters cluster near the middle of that range, management’s full-year net-sales guidance remains conservative at 3.75–4.75%, and consumer spending shows signs of frugality amid higher fuel costs in distribution. The 4.5–6% and 6–7.5% intervals together command 40% odds, reflecting potential upside from continued transaction growth and pharmacy volume if tariff-driven price increases lift average ticket without eroding unit demand. The earnings release expected around August 20 will resolve the market, with any material deviation from the 4% area likely driven by shifts in general-merchandise trends or pharmacy reimbursement changes.